PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098170
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2098170
Infertility Treatment Market Insights, Competitive Landscape, and Market Forecast - 2033
The Global Infertility Treatment Market is witnessing significant momentum as technological innovation, increasing awareness about reproductive health, and growing acceptance of assisted reproductive procedures continue to reshape the healthcare landscape. According to the latest market analysis, the Infertility Treatment Market is valued at USD 2.3 Billion in 2026 and is projected to reach USD 3.8 Billion by 2033, expanding at a CAGR of 8% during the forecast period.
The market is experiencing sustained growth due to rising infertility rates, delayed parenthood, lifestyle-related reproductive disorders, and the continuous evolution of fertility treatment technologies. Increasing investments in fertility clinics, supportive healthcare infrastructure, and improved access to advanced reproductive services are further strengthening market expansion across developed and emerging economies.
Introduction
Infertility has become a growing public health concern affecting millions of couples worldwide. Factors such as changing lifestyles, obesity, stress, hormonal disorders, environmental pollution, and increasing maternal age have significantly contributed to infertility prevalence among both men and women. As awareness surrounding reproductive health continues to improve, more individuals are actively seeking medical assistance through fertility treatments.
The infertility treatment industry encompasses a broad range of diagnostic procedures, medications, laboratory technologies, surgical interventions, and assisted reproductive technologies that help individuals and couples achieve successful pregnancies. Continuous innovation in reproductive medicine has substantially improved treatment success rates, making fertility services increasingly accessible and reliable.
Healthcare providers, biotechnology companies, pharmaceutical manufacturers, and fertility specialists continue to collaborate in developing advanced treatment protocols, improving laboratory equipment, and enhancing patient outcomes. As governments and private organizations focus on improving reproductive healthcare accessibility, the market is expected to witness considerable growth over the coming years.
Market Insights
The infertility treatment market continues to evolve with remarkable advancements in reproductive medicine and laboratory technologies. Assisted reproductive technologies have become increasingly sophisticated, offering higher success rates while minimizing procedural risks.
Modern fertility centers are integrating artificial intelligence, advanced embryo monitoring systems, genetic testing technologies, and automated laboratory equipment to improve treatment precision and clinical outcomes. These technological developments are transforming fertility care by enabling personalized treatment plans and more efficient reproductive procedures.
The increasing availability of specialized fertility centers, favorable reimbursement initiatives in selected countries, and expanding healthcare expenditure are further encouraging market growth. Additionally, improvements in cryopreservation techniques, embryo culture media, and laboratory consumables continue to enhance treatment efficiency while supporting long-term market development.
Market Drivers
Several important factors are contributing to the steady expansion of the infertility treatment market worldwide.
The growing incidence of infertility among both male and female populations remains one of the primary growth drivers. Lifestyle changes, smoking, alcohol consumption, obesity, diabetes, stress, and environmental pollutants have collectively increased reproductive health complications.
Delayed family planning due to educational, professional, and financial priorities has also resulted in greater demand for fertility treatments. Women choosing pregnancy later in life often require specialized reproductive assistance, increasing demand for advanced fertility procedures.
Technological advancements in reproductive medicine continue to improve success rates while reducing treatment complexity. Innovations in embryo selection, fertility preservation, genetic screening, and laboratory automation have significantly enhanced patient confidence and treatment outcomes.
Increasing awareness campaigns conducted by healthcare organizations and fertility specialists are encouraging early diagnosis and timely intervention, contributing to higher treatment adoption worldwide.
Business Opportunity
The infertility treatment market presents substantial opportunities for healthcare providers, biotechnology companies, pharmaceutical manufacturers, and medical device developers.
Rapid expansion of fertility clinics across emerging economies offers attractive investment prospects. Growing healthcare infrastructure and rising disposable income are enabling greater access to fertility services in developing countries.
The increasing adoption of fertility preservation techniques among cancer patients and individuals delaying parenthood creates additional growth opportunities for specialized treatment providers.
Manufacturers developing innovative laboratory equipment, embryo culture systems, cryopreservation technologies, fertility medications, and reproductive diagnostics are expected to benefit from increasing clinical demand.
Strategic collaborations between pharmaceutical companies, fertility clinics, research institutions, and biotechnology firms are accelerating innovation while expanding treatment accessibility across global markets.
Regional Analysis
North America continues to maintain a significant position in the infertility treatment market owing to advanced healthcare infrastructure, widespread adoption of assisted reproductive technologies, favorable regulatory support, and high awareness regarding reproductive health.
Europe remains an important regional market due to increasing infertility prevalence, strong healthcare systems, government support for fertility treatments in several countries, and continuous technological advancements in reproductive medicine.
Asia Pacific is expected to witness the fastest market growth during the forecast period. Rising healthcare investments, growing medical tourism, increasing awareness, expanding fertility clinic networks, and improving access to advanced reproductive technologies are driving regional demand.
Latin America is steadily emerging as a promising market due to improving healthcare accessibility, rising disposable income, and increasing investments in specialized fertility care.
The Middle East and Africa are gradually expanding their infertility treatment capabilities through healthcare modernization initiatives, increasing private healthcare investments, and growing awareness regarding reproductive health services.
Competitive Landscape
The global infertility treatment market remains highly competitive with leading companies focusing on product innovation, research and development, strategic partnerships, geographic expansion, and technological advancements.
Industry participants continue investing in advanced reproductive technologies, laboratory automation, embryo culture systems, fertility medications, and genetic testing solutions. Companies are also expanding manufacturing capabilities while strengthening distribution networks to improve product availability across international markets.
Continuous investments in research, clinical studies, and innovative reproductive healthcare solutions are expected to maintain healthy market competition throughout the forecast period.
Key Players
- The Cooper Companies Inc.
- Cook Group (Cook Medical)
- Thermo Fisher Scientific Inc.
- Vitrolife AB
- Merck KGaA
- Ferring Pharmaceuticals
- Organon & Co.
- Abbott Laboratories
- FUJIFILM Irvine Scientific Inc.
- Hamilton Thorne Ltd.
- Genea Biomedx
- Esco Micro Pte. Ltd.
- IVFtech ApS
- Kitazato Corporation
- The Baker Company Inc.
Market Segmentation
By Product
- Equipment
- Media & Consumables
- Accessories
By Procedure
- Assisted Reproductive Technology
- Artificial Insemination
- Fertility Surgeries
- Other Infertility Treatment Procedures
By Patient Type
- Female Infertility Treatment
- Male Infertility Treatment
By End User
- Fertility Centers
- Hospitals & Surgical Clinics
- Cryobanks
- Research Institutes
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Infertility Treatment Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Infertility Treatment Market Outlook, 2020-2033
- 3.1. Global Infertility Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 3.1.1. Equipment
- 3.1.2. Media & Consumables
- 3.1.3. Accessories
- 3.2. Global Infertility Treatment Market Outlook, by Procedure, Value (US$ Bn), 2020-2033
- 3.2.1. Assisted Reproductive Technology
- 3.2.2. Artificial Insemination
- 3.2.3. Fertility Surgeries
- 3.2.4. Other Infertility Treatment Procedures
- 3.3. Global Infertility Treatment Market Outlook, by Patient Type, Value (US$ Bn), 2020-2033
- 3.3.1. Female Infertility Treatment
- 3.3.2. Male Infertility Treatment
- 3.4. Global Infertility Treatment Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.4.1. Fertility Centers
- 3.4.2. Hospitals & Surgical Clinics
- 3.4.3. Cryobanks
- 3.4.4. Research Institutes
- 3.5. Global Infertility Treatment Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Infertility Treatment Market Outlook, 2020-2033
- 4.1. North America Infertility Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 4.1.1. Equipment
- 4.1.2. Media & Consumables
- 4.1.3. Accessories
- 4.2. North America Infertility Treatment Market Outlook, by Procedure, Value (US$ Bn), 2020-2033
- 4.2.1. Assisted Reproductive Technology
- 4.2.2. Artificial Insemination
- 4.2.3. Fertility Surgeries
- 4.2.4. Other Infertility Treatment Procedures
- 4.3. North America Infertility Treatment Market Outlook, by Patient Type, Value (US$ Bn), 2020-2033
- 4.3.1. Female Infertility Treatment
- 4.3.2. Male Infertility Treatment
- 4.4. North America Infertility Treatment Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.4.1. Fertility Centers
- 4.4.2. Hospitals & Surgical Clinics
- 4.4.3. Cryobanks
- 4.4.4. Research Institutes
- 4.5. North America Infertility Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Infertility Treatment Market Outlook, by Product, 2020-2033
- 4.5.2. U.S. Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 4.5.3. U.S. Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 4.5.4. U.S. Infertility Treatment Market Outlook, by End User, 2020-2033
- 4.5.5. Canada Infertility Treatment Market Outlook, by Product, 2020-2033
- 4.5.6. Canada Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 4.5.7. Canada Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 4.5.8. Canada Infertility Treatment Market Outlook, by End User, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Infertility Treatment Market Outlook, 2020-2033
- 5.1. Europe Infertility Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 5.1.1. Equipment
- 5.1.2. Media & Consumables
- 5.1.3. Accessories
- 5.2. Europe Infertility Treatment Market Outlook, by Procedure, Value (US$ Bn), 2020-2033
- 5.2.1. Assisted Reproductive Technology
- 5.2.2. Artificial Insemination
- 5.2.3. Fertility Surgeries
- 5.2.4. Other Infertility Treatment Procedures
- 5.3. Europe Infertility Treatment Market Outlook, by Patient Type, Value (US$ Bn), 2020-2033
- 5.3.1. Female Infertility Treatment
- 5.3.2. Male Infertility Treatment
- 5.4. Europe Infertility Treatment Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.4.1. Fertility Centers
- 5.4.2. Hospitals & Surgical Clinics
- 5.4.3. Cryobanks
- 5.4.4. Research Institutes
- 5.5. Europe Infertility Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Infertility Treatment Market Outlook, by Product, 2020-2033
- 5.5.2. Germany Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 5.5.3. Germany Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 5.5.4. Germany Infertility Treatment Market Outlook, by End User, 2020-2033
- 5.5.5. Italy Infertility Treatment Market Outlook, by Product, 2020-2033
- 5.5.6. Italy Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 5.5.7. Italy Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 5.5.8. Italy Infertility Treatment Market Outlook, by End User, 2020-2033
- 5.5.9. France Infertility Treatment Market Outlook, by Product, 2020-2033
- 5.5.10. France Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 5.5.11. France Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 5.5.12. France Infertility Treatment Market Outlook, by End User, 2020-2033
- 5.5.13. U.K. Infertility Treatment Market Outlook, by Product, 2020-2033
- 5.5.14. U.K. Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 5.5.15. U.K. Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 5.5.16. U.K. Infertility Treatment Market Outlook, by End User, 2020-2033
- 5.5.17. Spain Infertility Treatment Market Outlook, by Product, 2020-2033
- 5.5.18. Spain Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 5.5.19. Spain Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 5.5.20. Spain Infertility Treatment Market Outlook, by End User, 2020-2033
- 5.5.21. Russia Infertility Treatment Market Outlook, by Product, 2020-2033
- 5.5.22. Russia Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 5.5.23. Russia Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 5.5.24. Russia Infertility Treatment Market Outlook, by End User, 2020-2033
- 5.5.25. Rest of Europe Infertility Treatment Market Outlook, by Product, 2020-2033
- 5.5.26. Rest of Europe Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 5.5.27. Rest of Europe Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 5.5.28. Rest of Europe Infertility Treatment Market Outlook, by End User, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Infertility Treatment Market Outlook, 2020-2033
- 6.1. Asia Pacific Infertility Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 6.1.1. Equipment
- 6.1.2. Media & Consumables
- 6.1.3. Accessories
- 6.2. Asia Pacific Infertility Treatment Market Outlook, by Procedure, Value (US$ Bn), 2020-2033
- 6.2.1. Assisted Reproductive Technology
- 6.2.2. Artificial Insemination
- 6.2.3. Fertility Surgeries
- 6.2.4. Other Infertility Treatment Procedures
- 6.3. Asia Pacific Infertility Treatment Market Outlook, by Patient Type, Value (US$ Bn), 2020-2033
- 6.3.1. Female Infertility Treatment
- 6.3.2. Male Infertility Treatment
- 6.4. Asia Pacific Infertility Treatment Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.4.1. Fertility Centers
- 6.4.2. Hospitals & Surgical Clinics
- 6.4.3. Cryobanks
- 6.4.4. Research Institutes
- 6.5. Asia Pacific Infertility Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Infertility Treatment Market Outlook, by Product, 2020-2033
- 6.5.2. China Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 6.5.3. China Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 6.5.4. China Infertility Treatment Market Outlook, by End User, 2020-2033
- 6.5.5. Japan Infertility Treatment Market Outlook, by Product, 2020-2033
- 6.5.6. Japan Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 6.5.7. Japan Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 6.5.8. Japan Infertility Treatment Market Outlook, by End User, 2020-2033
- 6.5.9. South Korea Infertility Treatment Market Outlook, by Product, 2020-2033
- 6.5.10. South Korea Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 6.5.11. South Korea Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 6.5.12. South Korea Infertility Treatment Market Outlook, by End User, 2020-2033
- 6.5.13. India Infertility Treatment Market Outlook, by Product, 2020-2033
- 6.5.14. India Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 6.5.15. India Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 6.5.16. India Infertility Treatment Market Outlook, by End User, 2020-2033
- 6.5.17. Southeast Asia Infertility Treatment Market Outlook, by Product, 2020-2033
- 6.5.18. Southeast Asia Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 6.5.19. Southeast Asia Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 6.5.20. Southeast Asia Infertility Treatment Market Outlook, by End User, 2020-2033
- 6.5.21. Rest of SAO Infertility Treatment Market Outlook, by Product, 2020-2033
- 6.5.22. Rest of SAO Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 6.5.23. Rest of SAO Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 6.5.24. Rest of SAO Infertility Treatment Market Outlook, by End User, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Infertility Treatment Market Outlook, 2020-2033
- 7.1. Latin America Infertility Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 7.1.1. Equipment
- 7.1.2. Media & Consumables
- 7.1.3. Accessories
- 7.2. Latin America Infertility Treatment Market Outlook, by Procedure, Value (US$ Bn), 2020-2033
- 7.2.1. Assisted Reproductive Technology
- 7.2.2. Artificial Insemination
- 7.2.3. Fertility Surgeries
- 7.2.4. Other Infertility Treatment Procedures
- 7.3. Latin America Infertility Treatment Market Outlook, by Patient Type, Value (US$ Bn), 2020-2033
- 7.3.1. Female Infertility Treatment
- 7.3.2. Male Infertility Treatment
- 7.4. Latin America Infertility Treatment Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.4.1. Fertility Centers
- 7.4.2. Hospitals & Surgical Clinics
- 7.4.3. Cryobanks
- 7.4.4. Research Institutes
- 7.5. Latin America Infertility Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Infertility Treatment Market Outlook, by Product, 2020-2033
- 7.5.2. Brazil Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 7.5.3. Brazil Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 7.5.4. Brazil Infertility Treatment Market Outlook, by End User, 2020-2033
- 7.5.5. Mexico Infertility Treatment Market Outlook, by Product, 2020-2033
- 7.5.6. Mexico Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 7.5.7. Mexico Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 7.5.8. Mexico Infertility Treatment Market Outlook, by End User, 2020-2033
- 7.5.9. Argentina Infertility Treatment Market Outlook, by Product, 2020-2033
- 7.5.10. Argentina Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 7.5.11. Argentina Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 7.5.12. Argentina Infertility Treatment Market Outlook, by End User, 2020-2033
- 7.5.13. Rest of LATAM Infertility Treatment Market Outlook, by Product, 2020-2033
- 7.5.14. Rest of LATAM Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 7.5.15. Rest of LATAM Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 7.5.16. Rest of LATAM Infertility Treatment Market Outlook, by End User, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Infertility Treatment Market Outlook, 2020-2033
- 8.1. Middle East & Africa Infertility Treatment Market Outlook, by Product, Value (US$ Bn), 2020-2033
- 8.1.1. Equipment
- 8.1.2. Media & Consumables
- 8.1.3. Accessories
- 8.2. Middle East & Africa Infertility Treatment Market Outlook, by Procedure, Value (US$ Bn), 2020-2033
- 8.2.1. Assisted Reproductive Technology
- 8.2.2. Artificial Insemination
- 8.2.3. Fertility Surgeries
- 8.2.4. Other Infertility Treatment Procedures
- 8.3. Middle East & Africa Infertility Treatment Market Outlook, by Patient Type, Value (US$ Bn), 2020-2033
- 8.3.1. Female Infertility Treatment
- 8.3.2. Male Infertility Treatment
- 8.4. Middle East & Africa Infertility Treatment Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.4.1. Fertility Centers
- 8.4.2. Hospitals & Surgical Clinics
- 8.4.3. Cryobanks
- 8.4.4. Research Institutes
- 8.5. Middle East & Africa Infertility Treatment Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Infertility Treatment Market Outlook, by Product, 2020-2033
- 8.5.2. GCC Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 8.5.3. GCC Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 8.5.4. GCC Infertility Treatment Market Outlook, by End User, 2020-2033
- 8.5.5. South Africa Infertility Treatment Market Outlook, by Product, 2020-2033
- 8.5.6. South Africa Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 8.5.7. South Africa Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 8.5.8. South Africa Infertility Treatment Market Outlook, by End User, 2020-2033
- 8.5.9. Egypt Infertility Treatment Market Outlook, by Product, 2020-2033
- 8.5.10. Egypt Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 8.5.11. Egypt Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 8.5.12. Egypt Infertility Treatment Market Outlook, by End User, 2020-2033
- 8.5.13. Nigeria Infertility Treatment Market Outlook, by Product, 2020-2033
- 8.5.14. Nigeria Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 8.5.15. Nigeria Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 8.5.16. Nigeria Infertility Treatment Market Outlook, by End User, 2020-2033
- 8.5.17. Rest of Middle East Infertility Treatment Market Outlook, by Product, 2020-2033
- 8.5.18. Rest of Middle East Infertility Treatment Market Outlook, by Procedure, 2020-2033
- 8.5.19. Rest of Middle East Infertility Treatment Market Outlook, by Patient Type, 2020-2033
- 8.5.20. Rest of Middle East Infertility Treatment Market Outlook, by End User, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. The Cooper Companies Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Cook Group (Cook Medical)
- 9.4.3. Thermo Fisher Scientific Inc.
- 9.4.4. Vitrolife AB
- 9.4.5. Merck KGaA
- 9.4.6. Ferring Pharmaceuticals
- 9.4.7. Organon & Co.
- 9.4.8. Abbott Laboratories
- 9.4.9. FUJIFILM Irvine Scientific Inc.
- 9.4.10. Hamilton Thorne Ltd.
- 9.4.1. The Cooper Companies Inc.
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
